Who owns RENEO PHARMACEUTICALS INC?
- Ticker: RPHM
- CUSIP Number: 75974e103
Tip: Access positions for across all investors
Analyze quarterly positions in Reneo Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Reneo Pharmaceuticals stock
Who bought or sold RENEO PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| NEA Management Company | 4.8M | $7.9M | 0% | Mar 2024 |
|
| Tang Capital Management | 3.0M | $5.0M | -10% | Mar 2024 |
|
| Highbridge Capital Management | 2.7M | $4.5B | 144% | Mar 2024 |
|
| Carlyle | 2.7M | $4.5M | 0% | Mar 2024 |
|
| RiverVest Venture Management | 2.5M | $4.2B | 0% | Mar 2024 |
|
| Octagon Capital Advisors | 2.3M | $3.7M | 0% | Mar 2024 |
|
| BML Capital Management | 2.2M | $3.6M | 66% | Mar 2024 |
|
| BlackRock | 994k | $1.6M | 61% | Mar 2024 |
|
| Vanguard Group | 971k | $1.6M | -1% | Mar 2024 |
|
| Aisling Capital Management | 886k | $1.4M | 0% | Dec 2023 |
|
| Rock Springs Capital Management | 752k | $1.2M | -34% | Mar 2024 |
|
| Acuitas Investments | 404k | $671k | 100% | Mar 2024 |
|
| Aldebaran Capital | 396k | $658k | 100% | Mar 2024 |
|
| Geode Capital Management | 333k | $552k | 1% | Mar 2024 |
|
| Morgan Stanley | 227k | $377k | 603% | Mar 2024 |
|
| Bank Of Montreal | 134k | $228k | 100% | Mar 2024 |
|
| Susquehanna International | 132k | $219k | 100% | Mar 2024 |
|
| Two Sigma Investments | 131k | $217k | -28% | Mar 2024 |
|
| Northern Trust | 112k | $186k | -7% | Mar 2024 |
|
| GSA Capital Partners | 88k | $146k | -7% | Mar 2024 |
|
| JBF Capital | 80k | $133k | 100% | Mar 2024 |
|
| Marquette Asset Management | 74k | $123k | 100% | Mar 2024 |
|
| Citadel Advisors | 72k | $120k | -12% | Mar 2024 |
|
| Goldman Sachs Group | 39k | $64k | -40% | Mar 2024 |
|
| Charles Schwab Investment Management | 38k | $62k | 0% | Mar 2024 |
|
| Bank of New York Mellon | 34k | $57k | -22% | Mar 2024 |
|
| Fifth Lane Capital | 33k | $54k | -18% | Mar 2024 |
|
| Jump Financial | 25k | $41k | 100% | Dec 2023 |
|
| ALPS Advisors | 23k | $37k | 100% | Dec 2023 |
|
| Prospera Financial Services | 21k | $33k | 100% | Dec 2023 |
|
| CSS | 20k | $34k | 0% | Mar 2024 |
|
| Commonwealth Equity Services | 19k | $32k | 0% | Mar 2024 |
|
| American Century Companies | 18k | $30k | 100% | Mar 2024 |
|
| Nuveen Asset Management | 18k | $30k | 7% | Mar 2024 |
|
| Springbok Capital Management | 17k | $29k | 16% | Mar 2024 |
|
| Two Sigma Advisers | 16k | $27k | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 15k | $25k | -7% | Mar 2024 |
|
| Dimensional Fund Advisors | 13k | $22k | 0% | Mar 2024 |
|
| UBS Group | 12k | $20k | -28% | Mar 2024 |
|
| Rhumbline Advisers | 11k | $18k | 4% | Mar 2024 |
|
| Tower Research Capital | 9.5k | $16k | 541% | Mar 2024 |
|
| Barclays | 8.2k | $13k | -67% | Mar 2024 |
|
| Group One Trading | 7.6k | $13k | 100% | Mar 2024 |
|
| American International | 6.5k | $10k | 0% | Dec 2023 |
|
| China Universal Asset Management | 6.4k | $11k | 66% | Mar 2024 |
|
| Citigroup | 6.0k | $10k | 116% | Mar 2024 |
|
| Wells Fargo & Company | 5.3k | $8.8k | 10% | Mar 2024 |
|
| Bank of America Corporation | 4.4k | $7.3k | -82% | Mar 2024 |
|
| FMR | 1.6k | $2.7k | 343% | Mar 2024 |
|
| California State Teachers Retirement System | 1.5k | $2.4k | -49% | Mar 2024 |
|
| Legal & General Group | 1.4k | $2.4k | 0% | Mar 2024 |
|
| Torno Capital | 1.0k | $1.7k | -76% | Mar 2024 |
|
| Private Wealth Management Group | 821.00 | $1.4k | 100% | Mar 2024 |
|
| Summit Investment Advisors | 799.00 | $1.3k | 0% | Mar 2024 |
|
| Royal Bank of Canada | 744.00 | $1.7k | -73% | Mar 2024 |
|
| Federated Investors | 647.00 | $1.0k | -99% | Dec 2023 |
|
| New York State Common Retirement Fund | 637.00 | $1.0k | 188% | Mar 2024 |
|
| Pnc Financial Services | 395.00 | $656.016000 | 100% | Mar 2024 |
|
| Amalgamated Bank | 327.00 | $999.998700 | -72% | Mar 2024 |
|
| Russell Investments | 110.00 | $182.996000 | 100% | Mar 2024 |
|
| Advisor Group Holdings | 41.00 | $67.998500 | 0% | Mar 2024 |
|
| Farther Finance Advisors | 39.00 | $65.999700 | 100% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 2.00 | $3.000000 | 100% | Mar 2024 |
|
Who sold out of Reneo Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Ikarian Capital | Dec 2023 | 1.9M | $3.1M |
| Woodline Partners | Sep 2023 | 451k | $3.4M |
| Caption Management | Dec 2023 | 410k | $656k |
| ExodusPoint Capital Management | Sep 2023 | 379k | $2.9M |
| Millennium Management | Dec 2023 | 159k | $254k |
| LMR Partners | Dec 2023 | 120k | $192k |
| Bridgeway Capital Management | Sep 2023 | 91k | $696k |
| Hrt Financial | Dec 2023 | 87k | $139k |
| Jane Street | Dec 2023 | 79k | $126k |
| J. Goldman & Co | Dec 2023 | 68k | $108k |
| Adage Capital Partners GP | Sep 2023 | 65k | $495k |
| ADAR1 Capital Management | Dec 2023 | 40k | $64k |
| SG Americas Securities | Dec 2023 | 22k | $35k |
| Trexquant Investment | Sep 2023 | 21k | $158k |
| Point72 Middle East FZE | Dec 2023 | 14k | $22k |
| Dynamic Technology Lab Private | Dec 2023 | 13k | $20k |
| Schonfeld Strategic Advisors | Dec 2023 | 10k | $16k |
| Dorsey Wright & Associates | Sep 2023 | 3.7k | $28k |
| Cubist Systematic Strategies | Dec 2023 | 963.00 | $1.5k |